scholarly article | Q13442814 |
P2093 | author name string | Ying Jin | |
Yan Dong | |||
Qi Ding | |||
Sheng-xue Yu | |||
Hai-juan Sui | |||
Wen-hui Qu | |||
Ying-xin Jin | |||
P2860 | cites work | Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Q24295120 |
Mechanism of activation of protein kinase B by insulin and IGF-1 | Q24309528 | ||
Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway | Q24644113 | ||
RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1 | Q24682697 | ||
Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK | Q24798788 | ||
Seasonal patterns of infectious diseases | Q24809113 | ||
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B | Q27860731 | ||
TOR, a central controller of cell growth | Q27933354 | ||
Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2 | Q28181376 | ||
The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus | Q28257161 | ||
Upstream and downstream of mTOR | Q28277365 | ||
Hierarchical phosphorylation of the translation inhibitor 4E-BP1 | Q28363125 | ||
Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation | Q28378802 | ||
The inositol polyphosphate 5-phosphatase, PIPP, Is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation. | Q28583817 | ||
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway | Q28646919 | ||
Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb | Q28646935 | ||
Phosphatidylinositol-3-OH kinase as a direct target of Ras | Q29620177 | ||
Regulation of translation initiation by FRAP/mTOR | Q29620398 | ||
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling | Q29620489 | ||
Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway | Q30454351 | ||
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals | Q33688733 | ||
Ribosomal S6 kinase signaling and the control of translation | Q33783527 | ||
A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus | Q33898132 | ||
Mammalian target of rapamycin (mTOR) activation increases axonal growth capacity of injured peripheral nerves | Q34107374 | ||
Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo | Q34514599 | ||
Rho GTPases and activity-dependent dendrite development | Q35803104 | ||
The growing role of mTOR in neuronal development and plasticity. | Q36739424 | ||
Lovastatin inhibits amyloid precursor protein (APP) beta-cleavage through reduction of APP distribution in Lubrol WX extractable low density lipid rafts | Q37254798 | ||
Long-term benefits after treatment of traumatic brain injury with simvastatin in rats | Q37341566 | ||
Involvement of Akt in neurite outgrowth | Q37510693 | ||
Cholesterol and statins in Alzheimer's disease: current controversies | Q37603783 | ||
Simvastatin treatment improves functional recovery after experimental spinal cord injury by upregulating the expression of BDNF and GDNF | Q39654188 | ||
Mevastatin-induced neurite outgrowth of neuroblastoma cells via activation of EGFR. | Q39882609 | ||
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway | Q39946864 | ||
Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation | Q40192599 | ||
The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sites | Q40756366 | ||
Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k. | Q41106936 | ||
Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia | Q42552752 | ||
mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes | Q42809294 | ||
Cholesterol-dependent modulation of dendrite outgrowth and microtubule stability in cultured neurons. | Q43858169 | ||
HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells | Q44264417 | ||
Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke | Q44463534 | ||
Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury | Q44534829 | ||
HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis | Q44804955 | ||
A positive role of the PI3-K/Akt signaling pathway in PC12 cell differentiation. | Q45223846 | ||
Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones | Q45301947 | ||
Alzheimer-like plaque formation by human macrophages is reduced by fibrillation inhibitors and lovastatin | Q46350606 | ||
Lovastatin-induced PC-12 cell differentiation is associated with RhoA/RhoA kinase pathway inactivation | Q46541840 | ||
Simvastatin promotes heat shock protein 27 expression and Akt activation in the rat retina and protects axotomized retinal ganglion cells in vivo | Q46708089 | ||
Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. | Q46843627 | ||
Control of dendritic arborization by the phosphoinositide-3'-kinase-Akt-mammalian target of rapamycin pathway. | Q46843629 | ||
Simvastatin promotes neurite outgrowth in the presence of inhibitory molecules found in central nervous system injury | Q48426747 | ||
The 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibitor pravastatin enhances neurite outgrowth in hippocampal neurons. | Q48599703 | ||
Glycogen synthase kinase 3beta phosphorylation of microtubule-associated protein 1B regulates the stability of microtubules in growth cones. | Q52174232 | ||
Combined signaling through ERK, PI3K/AKT, and RAC1/p38 is required for met-triggered cortical neuron migration | Q81638656 | ||
P433 | issue | 7 | |
P921 | main subject | neurite | Q1534415 |
P304 | page(s) | 861–872 | |
P577 | publication date | 2012-07-01 | |
P1433 | published in | Acta Pharmacologica Sinica | Q15749885 |
P1476 | title | Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt/mTOR and Akt/GSK-3β signaling pathways | |
P478 | volume | 33 |
Q50352962 | A Salutary Role of Reactive Oxygen Species in Intercellular Tunnel-Mediated Communication. |
Q38443497 | Activation of mTOR: a culprit of Alzheimer's disease? |
Q47437415 | An Experimental Study of the Potential Biological Effects Associated with 2-D Shear Wave Elastography on the Neonatal Brain |
Q36194161 | Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3β-PP2Ac-NF-κB Signaling Axis. |
Q48659946 | Atorvastatin enhances kainate-induced gamma oscillations in rat hippocampal slices |
Q40378989 | Atorvastatin prevents Aβ oligomer-induced neurotoxicity in cultured rat hippocampal neurons by inhibiting Tau cleavage |
Q42198316 | Atorvastatin prevents amyloid-β peptide oligomer-induced synaptotoxicity and memory dysfunction in rats through a p38 MAPK-dependent pathway |
Q47932451 | Developmental neurotoxicity of the hippocampus following in utero exposure to methylmercury: impairment in cell signaling |
Q26768442 | Docosahexaenoic Acid and Cognition throughout the Lifespan |
Q39130546 | Dynamic change of SGK expression and its role in neuron apoptosis after traumatic brain injury |
Q46951155 | Evaluation of lovastatin effects on expression of anti-apoptotic Nrf2 and PGC-1α genes in neural stem cells treated with hydrogen peroxide. |
Q45053879 | Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS). |
Q38809645 | Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line |
Q36621106 | Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome |
Q96231011 | Intraperitoneal injection of IFN-γ restores microglial autophagy, promotes amyloid-β clearance and improves cognition in APP/PS1 mice |
Q91678331 | Molecular and Synaptic Bases of CDKL5 Disorder |
Q37153998 | Neuronal cholesterol metabolism increases dendritic outgrowth and synaptic markers via a concerted action of GGTase-I and Trk. |
Q27307798 | Novel High Content Screen Detects Compounds That Promote Neurite Regeneration from Cochlear Spiral Ganglion Neurons |
Q42414570 | PI3K mediated activation of GSK-3β reduces at-level primary afferent growth responses associated with excitotoxic spinal cord injury dysesthesias |
Q42178797 | PI3K/AKT/mTOR/p70S6K Pathway Is Involved in Aβ25-35-Induced Autophagy |
Q48206976 | Robust Neuritogenesis-Promoting Activity by Bis(heptyl)-Cognitin Through the Activation of alpha7-Nicotinic Acetylcholine Receptor/ERK Pathway. |
Q47641849 | Rosuvastatin Improves Neurite Outgrowth of Cortical Neurons against Oxygen-Glucose Deprivation via Notch1-mediated Mitochondrial Biogenesis and Functional Improvement |
Q39413658 | Statins and the Brain: More than Lipid Lowering Agents? |
Q41042432 | Study on the function and mechanism of atorvastatin in regulating leukemic cell apoptosis by the PI3K/Akt pathway. |
Q43243824 | The mechanistic target of rapamycin (mTOR) pathway and S6 Kinase mediate diazoxide preconditioning in primary rat cortical neurons. |
Q38978425 | Transcriptional and Epigenetic Regulation in Injury-Mediated Neuronal Dendritic Plasticity |
Q48277596 | U18666A, an activator of sterol regulatory element binding protein pathway, modulates presynaptic dopaminergic phenotype of SH-SY5Y neuroblastoma cells |
Q28266190 | β-Hydroxy-β-Methylbutyrate (HMB) Promotes Neurite Outgrowth in Neuro2a Cells |
Search more.